• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure.

作者信息

Christodoulides M, Sidey F M, Parton R, Stewart-Tull D E

机构信息

Department of Microbiology, University of Glasgow, Bearsden, UK.

出版信息

Vaccine. 1987 Sep;5(3):199-207. doi: 10.1016/0264-410x(87)90101-0.

DOI:10.1016/0264-410x(87)90101-0
PMID:2890244
Abstract

An extract containing predominantly pertussis toxin (PT) and filamentous haemagglutinin (FHa) was obtained from culture supernates of Bordetella pertussis by a single-step procedure using dye-ligand chromatography. The pathophysiological activities associated with the pertussis toxin component were removed by treatment with a water-soluble carbodiimide. The product was stable at 4 degrees C, was non-toxic for mice, induced high levels of IgG antibodies to both PT and FHa in vaccinated animals as judged by ELISA, and protected mice from intracerebral and intranasal challenge with B. pertussis.

摘要

相似文献

1
Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure.
Vaccine. 1987 Sep;5(3):199-207. doi: 10.1016/0264-410x(87)90101-0.
2
Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.鼻内联合使用重组霍乱毒素B亚单位作为佐剂后,小鼠针对无细胞百日咳疫苗的黏膜和全身抗体反应。
Vaccine. 2003 Mar 7;21(11-12):1165-73. doi: 10.1016/s0264-410x(02)00516-9.
3
A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin.一种制备无细胞百日咳疫苗的新方法,该疫苗由百日咳毒素的无热原类毒素和丝状血凝素组成。
Mol Immunol. 1991 Mar;28(3):251-5. doi: 10.1016/0161-5890(91)90070-z.
4
Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.对2月龄开始接种的无细胞、组分和全细胞百日咳疫苗的初次和加强剂量的反应。
Vaccine. 1996 Jun;14(9):916-22. doi: 10.1016/0264-410x(95)00257-2.
5
Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system.小鼠中的百日咳博德特氏菌感染:针对百日咳毒素和丝状血凝素这两种抗原的特异性抗体与小鼠在脑内或气溶胶攻击系统中的保护作用的相关性。
Infect Immun. 1984 Nov;46(2):415-21. doi: 10.1128/iai.46.2.415-421.1984.
6
Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.在两种不同小鼠品系中,针对百日咳杆菌Tn5突变体、纯化的百日咳毒素(PT)和丝状血凝素(FHA)的血清抗体反应以及在小鼠鼻内感染模型中的被动保护作用。
Microb Pathog. 1990 Jan;8(1):37-45. doi: 10.1016/0882-4010(90)90006-c.
7
Efficacy of chemically cross-linked antigens for acellular pertussis vaccine.化学交联抗原用于无细胞百日咳疫苗的效力
Vaccine. 2000 Dec 8;19(9-10):1199-203. doi: 10.1016/s0264-410x(00)00308-x.
8
A sensitive chemiluminescence assay for pertussis toxin and for evaluation of cell-free pertussis toxoids.一种用于百日咳毒素的灵敏化学发光测定法及无细胞百日咳类毒素的评估。
FEMS Microbiol Immunol. 1988 Jul;1(2):75-9. doi: 10.1111/j.1574-6968.1988.tb02494.x.
9
Acellular pertussis vaccines in infants: evaluation of single component and two-component products.婴儿用无细胞百日咳疫苗:单组分和双组分产品的评估
Vaccine. 1994 Jan;12(1):28-31. doi: 10.1016/0264-410x(94)90007-8.
10
Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.接种无细胞百日咳疫苗儿童中抗百日咳毒素IgG和抗丝状血凝素IgG的产生以及这些滴度与百日咳恢复期儿童血清的比较。
Dev Biol Stand. 1985;61:367-72.

引用本文的文献

1
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.基因失活百日咳毒素突变体的特性:一种新型百日咳疫苗的候选物
Infect Immun. 1990 May;58(5):1308-15. doi: 10.1128/iai.58.5.1308-1315.1990.